medical device investing Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
medical device investing Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
medical device investing Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
medical device investing Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
medical device investing Pulse Biosciences' nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium
medical device investing Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium
medical device investing Pulse Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
medical device investing Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
medical device investing Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse Technology
medical device investing Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
medical device investing Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
medical device investing Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
medical device investing Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
